Evidence map›Paper›PMID 24991923›Full record

Observational studyDiabetes technology & therapeutics2014

The Utah Remote Monitoring Project: improving health care one patient at a time.

Laura Shane-McWhorter, Leslie Lenert, Marta Petersen, Sarah Woolsey, Carrie McAdam-Marx, Jeffrey M Coursey, Thomas C Whittaker, Christian Hyer, Deb LaMarche, Patricia Carroll and 1 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Diabetes technology & therapeutics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Remote Patient Monitoring via Non-Invasive Digital Technologies: A Systematic Review.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2017
    Pooled it
  7. Article
  8. AI-Driven Management of Type 2 Diabetes in China: Opportunities and Challenges.Diabetes, metabolic syndrome and obesity : targets and therapy · 2025
    Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. The Need to Educate Pharmacy Students in Telepharmacy and Telehealth.American journal of pharmaceutical education · 2021
    Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Laura Shane-McWhorter1 Department of Pharmacotherapy, University of Utah College of Pharmacy , Salt Lake City, Utah.
Leslie Lenert
Marta Petersen
Sarah Woolsey
Carrie McAdam-Marx
Jeffrey M Coursey
Thomas C Whittaker
Christian Hyer
Deb LaMarche
Patricia Carroll
Libbey Chuy

Funding

PHS HHS H2ARH20160
6 · The paper itself

Abstract

backgroundThe expanding role of technology to augment diabetes care and management highlights the need for clinicians to learn about these new tools. As these tools continue to evolve and enhance improved outcomes, it is imperative that clinicians consider the role of telemonitoring, or remote monitoring, in patient care. This article describes a successful telemonitoring project in Utah. SUBJECTS AND

methodsThis was a nonrandomized prospective observational preintervention-postintervention study, using a convenience sample. Patients with uncontrolled diabetes and/or hypertension from four rural and two urban primary care clinics and one urban stroke center participated in a telemonitoring program. The primary clinical outcome measures were changes in hemoglobin A1C (A1C) and blood pressure. Other outcomes included fasting lipids, weight, patient engagement, diabetes knowledge, hypertension knowledge, medication adherence, and patient perceptions of the usefulness of the telemonitoring program.

resultsMean A1C decreased from 9.73% at baseline to 7.81% at the end of the program (P<0.0001). Systolic blood pressure also declined significantly, from 130.7 mm Hg at baseline to 122.9 mm Hg at the end (P=0.0001). Low-density lipoprotein content decreased significantly, from 103.9 mg/dL at baseline to 93.7 mg/dL at the end (P=0.0263). Other clinical parameters improved nonsignificantly. Knowledge of diabetes and hypertension increased significantly (P<0.001 for both). Patient engagement and medication adherence also improved, but not significantly. Per questionnaires at study end, patients felt the telemonitoring program was useful.

conclusionsTelemonitoring improved clinical outcomes and may be a useful tool to help enhance disease management and care of patients with diabetes and/or hypertension.

Indexed as

Drug MonitoringQuality ImprovementTelemedicineBlood PressureBlood Pressure DeterminationDiabetes Mellitus, Type 2FemaleGlycated HemoglobinHealth Knowledge, Attitudes, PracticeHumansHypertensionHypoglycemic AgentsLipoproteins, LDLMaleMedication AdherenceMiddle AgedGlycated Hemoglobinhemoglobin A1c protein, humanHypoglycemic AgentsLipoproteins, LDL

Identifiers

PMID24991923
PMCPMC4183896

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.